title: [Pharmacological and clinical profile of romiplostim (Romiplate(®) 250 µg for s.c. injection)].
authors: yoshihiro.furuya@kyowa-kirin.co.jp
authors: Yoshihiro
authors: Y
authors: Furuya
authors: Hiromi
authors: H
authors: Ishii
authors: Yukiko
authors: Y
authors: Aono
authors: Yasumasa
authors: Y
authors: Arai
authors: Fumiaki
authors: F
authors: Onda
authors: Kaname
authors: K
authors: Hasegawa
authors: Makoto
authors: M
authors: Yanagida
mesh_terms: D000818:Animals; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D007279:Injections, Subcutaneous; D008533:Megakaryocytes / Q000187:drug effects; D051379:Mice; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D011961:Receptors, Fc / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D015398:Signal Transduction; D013234:Stem Cells / Q000187:drug effects; D013926:Thrombopoietin / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim